TOURO INFIRMARY — History
CCN 190046 | 3-year financial timeline | COVID resilience: 85/100
🛡️ Public data only — no PHI permitted on this instance.
$369M
Latest Revenue (FY2022)
+22.5%
Revenue CAGR (3yr)
-3.7%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $246M | $329M | $369M | +12.5% | +22.5% |
| Operating Expenses | $332M | $355M | $383M | +8.1% | +7.5% |
| Operating Margin | -34.8% | -7.9% | -3.7% | +52.7% | +0.0% |
| Net Income | $-86M | $-26M | $-14M | +46.9% | +0.0% |
| Licensed Beds | 260 | 271 | 270 | -0.4% | +1.9% |
| Total Patient Days | 52,800 | 52,287 | 46,018 | -12.0% | -6.6% |
| Medicare Day % | 22% | 18% | 15% | -18.1% | -19.2% |
| Medicaid Day % | 3% | 2% | 1% | -11.7% | -27.7% |
COVID Impact & Recovery
Resilience Score: 85/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +50.0% ($246M → $369M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+22.5%
This Hospital
+7.6%
State Avg
Latest Margin
-3.7%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $431M | 11.8% |
| FY2024 (proj) | $493M | 27.3% |
| FY2025 (proj) | $554M | 42.8% |